GlassScriptPhysician profile
Marc D Benevides
NPI 1194765784
$8,966.62
in general payments reported to CMS, 2019-2025
42 companies · $1,934 in 2025
The $1,934 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,307 · 2020: $455 · 2021: $1,014 · 2022: $1,500 · 2023: $1,446 · 2024: $1,311 · 2025: $1,934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,690.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $2,026.05 | 2019-2025 | Provenge |
| Astellas Pharma US INC | $1,111.28 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Janssen Biotech, INC. | $834.90 | 2019-2025 | Erleada, Akeega, Abiraterone Acetate |
| Sumitomo Pharma America, INC. | $757.22 | 2023-2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $580.25 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Myriad Genetic Laboratories, INC. | $288.68 | 2020-2023 | Prolaris |
| Clarus Therapeutics INC. | $242.36 | 2020-2021 | |
| Urovant Sciences INC | $241.20 | 2021-2022 | |
| Accord Healthcare, INC. | $238.32 | 2022 | |
| Pfizer INC. | $209.69 | 2019-2025 | |
| Endo USA, INC. | $198.86 | 2024-2025 | Xiaflex |
| Kowa Pharmaceuticals America, INC. | $173.79 | 2022-2023 | Seglentis |
| Urogen Pharma, INC. | $171.50 | 2021-2024 | Jelmyto |
| Bioprotect Medical, INC. | $149.22 | 2025 | Bioprotect Balloon Implant System |
| Endo Pharmaceuticals INC. | $140.68 | 2019-2024 | Xiaflex |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Benevides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.